Linezolid APOTEX

País: Nova Zelanda

Idioma: anglès

Font: Medsafe (Medicines Safety Authority)

ingredients actius:

Linezolid 600mg

Disponible des:

Apotex NZ Ltd

Designació comuna internacional (DCI):

Linezolid 600 mg

Dosis:

600 mg

formulario farmacéutico:

Film coated tablet

Composición:

Active: Linezolid 600mg Excipient: Colloidal silicon dioxide Crospovidone Hyprolose Hypromellose Macrogol 8000 Magnesium stearate Methylcellulose Titanium dioxide

tipo de receta:

Prescription

Fabricat per:

Apotex Pharmachem India Pvt. Ltd.

indicaciones terapéuticas:

Linezolid APOTEX is indicated for the treatment of infections when known or suspected to be caused by susceptible organisms including those associated with concurrent bacteraemia such as: · Pneumonia - community acquired and nosocomial pneumonia · Skin and soft tissue infections · Enterococcal infections. Linezolid is active against Gram-positive bacteria only. Linezolid has no clinical activity against Gram-negative pathogens. Specific Gram-negative therapy is required if a concomitant Gram-negative pathogen is documented or suspected. Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Resumen del producto:

Package - Contents - Shelf Life: Blister pack, white opaque PVC film/Aluminium - 10 tablets - 12 months from date of manufacture stored at or below 30°C protect from light

Data d'autorització:

2014-03-28